Evidence map›Paper›PMID 33917912›Full record

ReviewMicroorganisms2021

The Nonribosomal Peptide Valinomycin: From Discovery to Bioactivity and Biosynthesis.

Shuhui Huang, Yushi Liu, Wan-Qiu Liu, Peter Neubauer, Jian Li

Abstract readReview
In one paragraph

Review in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Bioprospecting Indoor Bacteria Producing Bioactive Metabolites.Environmental microbiology reports · 2026
    Article
  2. Article
  3. ExploringMicrobiology (Reading, England) · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Beyond Flexible: Unveiling the Next Era of Flexible Electronic Systems.Advanced materials (Deerfield Beach, Fla.) · 2024
    Review
  13. Three New Depsipeptides, Homiamides A-C, Isolated fromMolecules (Basel, Switzerland) · 2024
    Article
  14. Article
  15. Article
  16. Impact ofEngineering microbiology · 2024
    Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shuhui HuangSchool of Physical Science and Technology, ShanghaiTech University, Shanghai 201210, China.
Yushi LiuSchool of Physical Science and Technology, ShanghaiTech University, Shanghai 201210, China.
Wan-Qiu LiuSchool of Physical Science and Technology, ShanghaiTech University, Shanghai 201210, China.
Peter NeubauerChair of Bioprocess Engineering, Department of Biotechnology, Technische Universität Berlin, 13355 Berlin, Germany.ORCID 0000-0002-1214-9713
Jian LiSchool of Physical Science and Technology, ShanghaiTech University, Shanghai 201210, China.ORCID 0000-0003-2359-238X

Funding

National Natural Science Foundation of China 31800720National Natural Science Foundation of China 31971348Natural Science Foundation of Shanghai No. 19ZR1477200ShanghaiTech University starting grant
6 · The paper itself

Abstract

Valinomycin is a nonribosomal peptide that was discovered from

Indexed as

bioactivitiesbiosynthesiscell-free biosynthesisheterologous productionnonribiosomal peptideStreptomycesvalinomycin

Identifiers

PMID33917912
PMCPMC8068249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.